{"acute myeloid leukaemia": 9.84, "anaemia": 3.46, "anaphylactic reaction": 3.98, "anaphylactic shock": 3.3, "anaphylactoid reaction": 6.81, "aphthous ulcer": 2.85, "ascites": 2.84, "back pain": 5.82, "blister": 2.23, "breast cancer metastatic": 8.76, "bronchospasm": 8.8, "cardiac failure": 2.2, "cardiotoxicity": 20.15, "chest discomfort": 3.35, "cyanosis": 4.44, "dermatitis": 4.07, "dermatitis bullous": 8.41, "disease progression": 5.32, "dyspnoea": 2.52, "ejection fraction decreased": 7.59, "erythema": 5.44, "extravasation": 18.0, "febrile neutropenia": 7.63, "feeling hot": 2.86, "flushing": 15.29, "haematotoxicity": 9.98, "hepatotoxicity": 2.88, "hot flush": 2.33, "hypersensitivity": 5.21, "hypotension": 2.14, "hypoxia": 2.78, "infusion related reaction": 66.12, "infusion site reaction": 31.3, "interstitial lung disease": 10.24, "intestinal obstruction": 3.84, "laryngeal oedema": 4.74, "leukopenia": 4.31, "metastases to liver": 3.54, "mouth ulceration": 2.88, "mucosal inflammation": 23.27, "myelodysplastic syndrome": 3.31, "neoplasm progression": 3.51, "neutropenia": 7.29, "neutropenic sepsis": 9.11, "off label use": 4.82, "ovarian cancer": 14.92, "oxygen saturation decreased": 2.6, "palmar-plantar erythrodysaesthesia syndrome": 99.89, "pancytopenia": 4.93, "plasma cell myeloma": 3.32, "polyneuropathy": 2.79, "product use in unapproved indication": 10.91, "sense of oppression": 13.08, "sepsis": 2.37, "skin exfoliation": 4.45, "skin hyperpigmentation": 14.68, "skin lesion": 2.83, "skin reaction": 5.7, "skin toxicity": 34.25, "skin ulcer": 4.58, "stomatitis": 10.07, "throat tightness": 3.18, "thrombocytopenia": 3.64, "toxic epidermal necrolysis": 3.31, "toxic skin eruption": 10.71, "transaminases increased": 2.03}